KEGG: bcz:BCE33L2478
BCE33L2478 is an uncharacterized protein family (UPF0421) protein from Bacillus cereus with UniProt ID Q63AK0. The full-length protein consists of 355 amino acids and contains predicted transmembrane domains. Analysis of its amino acid sequence suggests it may function as a membrane protein involved in transport or signaling pathways. When expressed recombinantly, it is typically produced with an N-terminal histidine tag to facilitate purification .
Initial characterization should follow a systematic approach:
Confirm protein identity by SDS-PAGE and Western blotting with anti-His antibodies
Verify protein purity (>90% as typically supplied)
Perform mass spectrometry to confirm molecular weight
Analyze secondary structure using circular dichroism spectroscopy
Assess oligomeric state through size exclusion chromatography
Evaluate thermal stability using differential scanning fluorimetry
Proper reconstitution is critical for maintaining protein functionality:
Centrifuge the vial briefly before opening to collect powder at the bottom
Reconstitute in deionized sterile water to 0.1-1.0 mg/mL concentration
For long-term storage, add glycerol to a final concentration of 5-50% (typically 50%)
Aliquot and store at -20°C/-80°C to avoid repeated freeze-thaw cycles
Reconstituted protein should be stored in Tris/PBS-based buffer with 6% trehalose at pH 8.0
The optimal expression system for BCE33L2478 is E. coli, as demonstrated in the commercially available recombinant product . For researchers designing their own expression protocols:
| Expression Parameter | Recommended Condition | Rationale |
|---|---|---|
| Expression strain | BL21(DE3), C41(DE3), or C43(DE3) | Better for membrane/toxic proteins |
| Induction temperature | 16-20°C | Promotes proper folding |
| IPTG concentration | 0.1-0.5 mM | Moderate induction prevents aggregation |
| Media | Terrific Broth or auto-induction | Higher biomass and protein yield |
| Expression time | 16-20 hours | Extended time at lower temperature |
A multi-step purification approach is recommended:
Immobilized Metal Affinity Chromatography (IMAC) using Ni-NTA resin to capture the His-tagged protein
Size exclusion chromatography to remove aggregates and contaminants
If necessary, ion exchange chromatography as a polishing step
For membrane proteins, include appropriate detergents throughout purification
The final purity should exceed 90% as determined by SDS-PAGE, consistent with commercial preparations .
BCE33L2478, as a potential membrane protein, may present solubility challenges:
Screen multiple detergents (DDM, LDAO, LMNG) at various concentrations
Test buffer conditions with varying pH (6.5-8.5) and salt concentrations (100-500 mM NaCl)
Include stabilizing agents such as glycerol (5-20%) or specific lipids
Consider membrane-mimetic systems like nanodiscs or liposomes for functional studies
Maintain protein at concentrations below aggregation threshold (<5 mg/mL initially until stability is determined)
Several complementary computational approaches should be employed:
| Prediction Tool | Application | Expected Output |
|---|---|---|
| TMHMM/HMMTOP | Transmembrane topology | Predicted TM segments |
| AlphaFold2 | 3D structure prediction | Complete structural model |
| ConSurf | Evolutionary conservation | Functionally important residues |
| SignalP | Signal peptide prediction | Potential secretion signals |
| InterProScan | Domain identification | Functional domains |
| PredictProtein | Secondary structure | α-helices, β-sheets distribution |
To experimentally verify membrane topology:
Cysteine-scanning mutagenesis combined with accessibility assays
Protease protection assays to identify cytoplasmic vs. periplasmic regions
GFP-fusion reporter assays at N and C termini
Site-directed fluorescence labeling at predicted loop regions
EPR spectroscopy with spin-labeled residues
Antibody epitope mapping against predicted extramembrane regions
For high-resolution structural analysis:
X-ray crystallography after detergent screening and crystallization optimization
Cryo-electron microscopy for protein in detergent micelles or nanodiscs
NMR spectroscopy for specific domains or dynamic regions
Hydrogen-deuterium exchange mass spectrometry for conformational dynamics
Small-angle X-ray scattering for low-resolution shape determination in solution
Function identification requires multiple complementary approaches:
Sequence-based predictions using tools like InterPro, Pfam, and MOTIF
Structural homology to characterized proteins using Dali or VAST
Genomic context analysis - neighboring genes often have related functions
Gene co-expression analysis across different growth conditions
Phenotypic analysis of BCE33L2478 knockout strains in B. cereus
Heterologous expression in model organisms with defined phenotypic readouts
To investigate potential roles in virulence:
Generate gene deletion mutants in virulent B. cereus strains
Compare enterotoxin production (HBL, NHE, CytK, EntFM) between wild-type and mutant strains
Assess adhesion and invasion of epithelial cells
Evaluate cytotoxicity using cell culture models
Analyze biofilm formation capacity
Test survival under conditions mimicking host environments (low pH, oxidative stress)
Perform transcriptomic analysis to identify co-regulated virulence factors
Protein interaction studies should include:
Affinity purification using His-tagged BCE33L2478 followed by mass spectrometry
Bacterial two-hybrid screening against B. cereus genomic library
Co-immunoprecipitation studies with antibodies against predicted interaction partners
Crosslinking mass spectrometry to capture transient interactions
Proximity labeling approaches (BioID, APEX) in native B. cereus
While specific information about BCE33L2478's role in pathogenicity is limited, research approaches should consider:
Analyzing expression patterns during different growth phases and infection conditions
Investigating conservation across B. cereus strains with varying virulence profiles
Examining correlation with known virulence factors like enterotoxins (HBL, NHE) and emetic toxin
Determining if BCE33L2478 is regulated by known virulence regulators like PlcR
To investigate potential relationships with antibiotic resistance:
Compare expression levels in antibiotic-resistant versus susceptible strains
Test if knockout affects susceptibility to β-lactams and other antibiotics
Determine if BCE33L2478 can function as an efflux pump for antibiotics
Analyze if it contributes to membrane permeability or modification
B. cereus exhibits resistance to several antibiotics, particularly β-lactams, with resistance rates of 100% to penicillin, 99.73% to ampicillin, and 97.83% to amoxicillin-clavulanic acid .
Researchers should conduct comparative genomic analysis:
Analyze conservation across diverse B. cereus isolates from different sources
Determine if BCE33L2478 is part of the core genome or accessory genome
Identify sequence variations that might correlate with strain virulence
Use multilocus sequence typing (MLST) approaches similar to those used for general B. cereus characterization
Examine if the gene is located near any mobile genetic elements or pathogenicity islands
For effective mutagenesis studies:
Identify conserved residues through multiple sequence alignment of UPF0421 family proteins
Target predicted functional motifs based on computational analysis
Design an alanine-scanning strategy for initial functional mapping
Include both conserved and non-conserved residues as experimental controls
Verify mutant protein expression, folding, and stability before functional interpretation
Ensure proper experimental controls (wild-type protein, empty vector)
To determine cellular localization:
Generate C-terminal or N-terminal fluorescent protein fusions (considering predicted topology)
Perform subcellular fractionation followed by Western blotting
Use immunogold electron microscopy with specific antibodies
Create GFP reporter fusions to study expression patterns under different conditions
Use fluorescence microscopy to track dynamic localization during growth and division
Critical controls include:
Wild-type protein expression alongside mutant constructs
Empty vector controls for expression studies
Complementation of knockout strains to confirm phenotype specificity
Heat-inactivated protein controls for enzymatic assays
Scrambled peptide controls for binding studies
Non-related membrane protein controls of similar size/topology
Multiple B. cereus strains to account for strain-specific effects
Integrated systems approaches should include:
Transcriptomic analysis comparing wild-type and BCE33L2478 mutants under various conditions
Proteomic profiling to identify changes in protein expression and post-translational modifications
Metabolomic analysis to detect alterations in metabolic pathways
Network analysis to identify pathways influenced by BCE33L2478
Innovative approaches include:
Nanodiscs or styrene-maleic acid lipid particles (SMALPs) for detergent-free purification
Single-molecule fluorescence techniques to study conformational dynamics
In-cell NMR for structural studies in native-like environments
Microfluidic approaches for high-throughput functional screening
Genetic code expansion for site-specific incorporation of unnatural amino acids
Cryo-electron tomography for in situ structural analysis
Comparative analysis should:
Identify functionally characterized UPF0421 family members in other bacteria
Conduct phylogenetic analysis to understand evolutionary relationships
Map conserved motifs that might indicate functional sites
Transfer functional insights from characterized homologs
Identify species-specific features that might relate to B. cereus pathogenicity
| Function Category | Assay Method | Expected Readout | Technical Considerations |
|---|---|---|---|
| Membrane Transport | Liposome reconstitution with fluorescent substrates | Substrate uptake or efflux | Requires stable reconstitution in liposomes |
| Ion Channel Activity | Patch-clamp electrophysiology | Ion conductance | Requires formation of stable membrane patches |
| Substrate Binding | Isothermal titration calorimetry | Binding affinity (Kd) | Requires pure, stable protein |
| Enzymatic Activity | Coupled enzyme assays | Substrate conversion | Dependent on hypothesized function |
| Protein-Protein Interaction | Pull-down followed by MS | Identified binding partners | May require crosslinking for transient interactions |
| Virulence Contribution | Infection assays with knockout strains | Changes in virulence markers | Requires generation of genetic knockouts |